ResMed Inc.
- RMD
- NYSE
- Medical - Instruments & Supplies
- Sleep Apnea/Respiratory Devices
- Healthcare SaaS
$245.50
Today +2.39%Quote Oct 20, 2026, 08:00 PM UTC
+9.79%over the last month
Max drawdown −2.1%From 1-month high 0.0%3 months +27.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About ResMed
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service.
Where the money comes from
Q2 2026 revenue $1.42B
- Sleep And Respiratory$1.26B88.3%
- Residential Care Software$166.9M11.7%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Employees
11,370
Founded
1989
Market value
$34.53B
Quote Oct 20
Floor
$244.89
0.2% below price
Resistance
$250.69
2.1% above price
Price vs analyst targets
35 analysts
Lowest target
$213.00Highest target
$300.00
$213.00Highest target
$300.00
- Price $245.50
- Average target $243.56
- Analysts' target range
Analysts' average target sits about 1% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RMDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free